AAMC Home   Tomorrow's Doctors Tomorrow's Cures
  Home  Government Affairs   Newsroom   Meetings   Publications Shopping Cart   Site Map    

Home

Washington Highlights

Testimony & Correspondence

Top Issues:

 

Education

 

GME & IME Payments

HIPAA

Labor-HHS Appropriations

Research

Teaching Hospitals

Teaching Physicians

Veterans Affairs

Workforce

Government Affairs & Advocacy Site Map

Contact

 

Government Affairs Home > Washington Highlights > February 7, 2003

Senators Introduce Bipartisan Cloning Bill

February 7, 2003 - Senators Orrin Hatch (R-Utah), Dianne Feinstein (D-Calif.), Arlen Specter (R-Pa.), Edward Kennedy (D-Mass.), Tom Harkin (D-Iowa), and Zell Miller (D-Ga.) re-introduced legislation Feb. 5 to ban human reproductive cloning but to allow somatic cell nuclear transplantation (SCNT), sometimes called "therapeutic cloning," to move ahead with federal oversight.

The "Human Cloning Ban and Stem Cell Protection Act of 2003" (S. 303), makes it a crime, punishable by up to 10 years in prison and fines of $1 million or three times any profits made, whichever is greater, on any person who clones or attempts to clone a human being. The bill permits nuclear transplantation to be conducted on unfertilized eggs for up to 14 days, under strict ethical and federal regulation. The bill requires that all egg donations be voluntary, prohibits large payments to women to induce egg donations, and prohibits the purchase or sale of unfertilized eggs, including eggs that have undergone nuclear transplantation. The bill also requires informed consent by egg donors, review of any nuclear transplantation research by an ethics board and safety, and mandates privacy protections. The exportation of eggs that have undergone nuclear transplantation to any foreign country that does not ban human cloning also is prohibited.


The AAMC has endorsed S. 303. In a Jan. 15 letter (PDF, 1 page - 58KB) to Senator Hatch, AAMC President Jordan J. Cohen, M.D., stated, "We recognize the significant ethical issues that are raised about embryonic stem cell research and we respect the view of those who oppose such research, including some in our own medical school community. However, we are persuaded otherwise by what we believe is an equally compelling ethical consideration, namely, the unique potential afforded by embryonic stem cells, to alleviate human suffering and enhance the quality of human life."

Information:
Dave Moore, Senior Associate Vice President
AAMC Government Relations
dbmoore@aamc.org
(202) 828-0525

This page contains documents in Portable Document Format (PDF). The Adobe Acrobat® Reader® is required to view PDF documents. Download Acrobat® Reader®.

e-mail icon Get Washington Highlights in your Inbox!

Contact Us    © 1995-2008 AAMC    Terms and Conditions    Privacy Statement